BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19647426)

  • 1. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.
    Raut CP; Nucci MR; Wang Q; Manola J; Bertagnolli MM; Demetri GD; Morgan JA; Muto MG; Fletcher CD; George S
    Eur J Cancer; 2009 Nov; 45(16):2818-24. PubMed ID: 19647426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: a study of 86 cases.
    Lim D; Wang WL; Lee CH; Dodge T; Gilks B; Oliva E
    Gynecol Oncol; 2013 Feb; 128(2):322-6. PubMed ID: 23153591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
    Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-institution validation of the AJCC staging system for stage IV melanoma.
    Neuman HB; Patel A; Ishill N; Hanlon C; Brady MS; Halpern AC; Houghton A; Coit DG
    Ann Surg Oncol; 2008 Jul; 15(7):2034-41. PubMed ID: 18465172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and assessment of staging systems for head and neck soft tissue sarcomas in adults.
    Van Damme JP; Schmitz S; Machiels JP; Galant C; Grégoire V; Lengelé B; Hamoir M
    Eur J Surg Oncol; 2010 Jul; 36(7):684-90. PubMed ID: 20542404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO staging for carcinosarcoma: can the revised staging system predict overall survival?
    Pradhan TS; Stevens EE; Ablavsky M; Salame G; Lee YC; Abulafia O
    Gynecol Oncol; 2011 Nov; 123(2):221-4. PubMed ID: 21889193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE; Asrari F; Trimble EL; Montz FJ
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
    Zivanovic O; Leitao MM; Iasonos A; Jacks LM; Zhou Q; Abu-Rustum NR; Soslow RA; Juretzka MM; Chi DS; Barakat RR; Brennan MF; Hensley ML
    J Clin Oncol; 2009 Apr; 27(12):2066-72. PubMed ID: 19255317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.
    Loizzi V; Cormio G; Nestola D; Falagario M; Surgo A; Camporeale A; Putignano G; Selvaggi L
    Oncology; 2011; 81(2):91-7. PubMed ID: 21968290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease.
    Han M; Walsh PC; Partin AW; Rodriguez R
    J Urol; 2000 Jul; 164(1):89-92. PubMed ID: 10840430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
    Roach M; Weinberg V; Sandler H; Thompson I
    Cancer; 2007 Jan; 109(2):213-20. PubMed ID: 17167758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.
    Iasonos A; Keung EZ; Zivanovic O; Mancari R; Peiretti M; Nucci M; George S; Colombo N; Carinelli S; Hensley ML; Raut CP
    Cancer; 2013 May; 119(10):1816-22. PubMed ID: 23456762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
    Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.
    Lei HJ; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
    J Am Coll Surg; 2006 Oct; 203(4):426-35. PubMed ID: 17000385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.